Literature DB >> 16288546

A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Duke M Fitch1, Karen A Evans, Deping Chai, Kevin J Duffy.   

Abstract

[reaction: see text] An efficient two-pot, asymmetric synthesis of benzothiadiazine-substituted tetramic acids is reported. Starting from commercially available alpha-amino acids or esters, reductive amination followed by a novel one-pot amide bond formation/Dieckmann cyclization provided the desired products in high yield and optical purity. An analogous solid-phase approach to the same targets is also presented. These compounds were found to be potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288546     DOI: 10.1021/ol052371w

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.

Authors:  Ji-Min Sun; Seong-Jun Kim; Geon-Woo Kim; Jin-Kyu Rhee; Nam Doo Kim; Heeyong Jung; Jungae Jeun; Seung-Hoon Lee; Seung Hyun Han; Chul Soo Shin; Jong-Won Oh
Journal:  J Antimicrob Chemother       Date:  2011-11-09       Impact factor: 5.790

2.  Microwave-assisted efficient and facile synthesis of tetramic acid derivatives via a one-pot post-Ugi cascade reaction.

Authors:  Yong Li; Zheng Huang; Jia Xu; Yong Ding; Dian-Yong Tang; Jie Lei; Hong-Yu Li; Zhong-Zhu Chen; Zhi-Gang Xu
Journal:  Beilstein J Org Chem       Date:  2020-04-09       Impact factor: 2.883

3.  Highly functionalized 1,2-diamino compounds through reductive amination of amino acid-derived β-keto esters.

Authors:  Paula Pérez-Faginas; M Teresa Aranda; M Teresa García-López; Lourdes Infantes; Asia Fernández-Carvajal; José Manuel González-Ros; Antonio Ferrer-Montiel; Rosario González-Muñiz
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.